China Resources Sanjiu Medical & Pharmaceutical Chinese Medicine

China Resources Sanjiu Medical & Pharmaceutical Chinese Medicine is presented as a traditional Chinese medicine business or brand designation associated with China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., a Chinese pharmaceutical company within the China Resources group. The available identification does not establish that the subject is a separately incorporated company, a single consumer-facing trademark, or a formally defined subsidiary with an independent corporate history. It is therefore best treated conservatively as a business or brand area connected with China Resources Sanjiu's traditional Chinese medicine activities rather than as an independently verified legal entity. The designation relates to the development, manufacture, marketing, and distribution of traditional Chinese medicine and Chinese patent medicine products. Such products may be sold through pharmacies, hospitals, clinics, e-commerce channels, and other healthcare retail channels in China, but the specific product portfolio, trademarks, manufacturing sites, and international footprint attributable exclusively to this designation have not been verified from the supplied material. China Resources Sanjiu is associated with the broader China Resources healthcare and pharmaceutical portfolio. However, ownership, management, establishment date, operating scope, and financial information for the specific Chinese medicine designation should not be inferred automatically from information about the listed parent company. Further verification is required to determine whether the name is used as an official division name, a product-category label, a marketing description, or a distinct brand architecture element. Because no reliable Wikipedia article, authoritative website, ticker, or source documents were supplied for the exact subject name, this entry intentionally omits unsupported founding dates, executives, products, campaigns, controversies, financial figures, and corporate transactions. The subject should be reviewed against official corporate filings, China Resources Sanjiu's brand and product materials, Chinese pharmaceutical registration records, and authoritative company disclosures before being used as a fully verified encyclopedia entry.

The exact historical status of China Resources Sanjiu Medical & Pharmaceutical Chinese Medicine cannot be established from the supplied reference material. The name appears to describe traditional Chinese medicine activities linked to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., but there is insufficient evidence to determine whether it represents a separately registered company, a business division, a product portfolio, or a consumer brand. The broader China Resources Sanjiu organization operates within the China Resources group and is associated with pharmaceutical and healthcare products in China. That corporate context provides a useful framework for understanding the subject, but it does not prove that every product, executive, milestone, or corporate event attributed to China Resources Sanjiu belongs specifically to the Chinese medicine designation. A separate chronology should therefore not be constructed without primary documentation. No verified founding year, founder, headquarters, independent ownership structure, website, public listing details, product catalogue, campaign history, litigation record, recall record, or leadership roster has been identified for the exact subject name in the provided material. The absence of such information is not evidence that these events or attributes do not exist; it indicates that they require source-level confirmation. Official company disclosures and Chinese regulatory product-registration records would be needed to establish the business's legal identity, historical development, product scope, and current status.

Traditional Chinese medicine and Chinese patent medicine activities associated with China Resources Sanjiu, serving the Chinese healthcare and pharmaceutical market.

• 2015

  CR Sanjiu Subsidiary Recalls Shuxuening Injection After Sampling Failure, Suspends Production and Sales

  Securities Times reported that a sampling test on February 17, 2015 found two batches of China Resources Gaoke's Shuxuening Injection to be substandard. The company recalled the relevant batches and proactively expanded the recall, suspended production and sales of the product, and carried out risk assessment and rectification. The company said at the time that it had not received reports of serious adverse reactions. Progress: The company's announcement confirmed the recall and suspension of production and sales. Entities involved: Beijing China Resources Gaoke Natural Medicine Co., Ltd. and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Scope: An incident related to CR Sanjiu's traditional Chinese medicine business, limited to the subsidiary's Shuxuening product.

  Source

Read more

1. 1CR Sanjiu Subsidiary Recalls Shuxuening Injection After Sampling Failure, Suspends Production and Salesepaper.stcn.com